Negative regulation of B cell mediated immunity

pathway activity — cross-omics
GO:0002713Cross-omicsPROTEIN-MS → PROTEIN-MSPatientPairwise association · TCGA cohorts

Across TCGA patient cohorts, RNA activity of the Negative regulation of B cell mediated immunity pathway is significantly associated with the protein abundance of multiple proteins, with the HNSC cohort showing a particularly strong set of associations.

The most reproducible pathway-associated proteins across cancer lineages are BCL6_S343, BCL6_S404, and BCL6_S333, each associated with the pathway in up to 5 cancer types. Since the analysis shows associations rather than directional relationships, both pathway-to-partner and partner-to-pathway views are reported.

Each partner is linked to its corresponding Q-omics profile. The scatter plot shows the strongest association, Negative regulation of B cell mediated immunity activity versus BCL6_S343 in HNSC (Pearson r = 0.11).

Pathway-associated proteins by consensus

Ranked by combined sampling and lineage consensus. X-score (pathway→partner) and Y-score (partner→pathway) are standardized regression coefficients; both directions are reported because the association is undirected. The reported p-values are derived from the association test.
LineagePartner proteinX-scoreY-scorep(X)p(Y)Sampling consensusLineage consensus
HNSCBCL6_S343 →+0.601+0.319<.001<.00135
BRCABCL6_S404 →+0.851+0.713<.001<.00135
GBMBCL6_S333 →+0.528+0.327<.001<.00134
UCECBCL6_S457 →+0.896+0.416<.001.00225
OVRIN3_S524 →+1.088+0.229.003<.00132
OVRPS6KC1_S664 →-1.525-0.388<.001<.00132
Each partner links to its Q-omics profile. Showing the 6 strongest associations by consensus.

GO:0002713 vs BCL6_S343 — HNSC

Per-sample scatter of Negative regulation of B cell mediated immunity activity vs BCL6_S343 in HNSC.

Explore this scatter interactively →

Exploration